Atlas Trials

A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

Clinical trial NCT01353664 · COMPLETED

Trial details

NCT number
NCT01353664
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LymphomaCancer
Start date
2011-05-01
Primary completion
2012-09-05
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.